Product image of Ifirmasta (Irbesartan) supplied by GNH India

Ifirmasta

Active Ingredient:
Irbesartan
Origin:
EU

Ifirmasta (Irbesartan)

Irbesartan, the active ingredient in Ifirmasta, is an angiotensin II receptor blocker presented as an oral tablet for oral use. It lowers elevated blood pressure and helps protect kidney function in adults with hypertension or type 2 diabetes‑related renal impairment.

GNH India supplies Ifirmasta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to quality‑assured medicines across global markets. The company adheres to stringent regulatory standards to ensure product integrity throughout the supply chain.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Ifirmasta (irbesartan) acts on the renin‑angiotensin‑aldosterone system to manage cardiovascular and renal conditions.
  • Hypertension: reduces systolic and diastolic blood pressure, decreasing cardiovascular risk.
  • Diabetic nephropathy (type 2 diabetes with renal impairment): slows progression of kidney damage and reduces proteinuria.
  • Proteinuria associated with diabetic kidney disease: lowers urinary protein excretion, supporting renal preservation.

How It Works

  • Irbesartan selectively antagonizes angiotensin II type 1 (AT1) receptors on vascular smooth muscle, adrenal gland, and renal tubular cells. By blocking AT1 activation, it prevents vasoconstriction, aldosterone release, and sodium‑water retention, leading to reduced peripheral resistance, lower blood pressure, and decreased intraglomerular pressure that helps preserve kidney function.

Side Effects

Irbesartan may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Dizziness or light‑headedness
  • Headache
  • Fatigue
  • Nasal congestion or cough
  • Elevated serum potassium (hyperkalaemia)

Serious or Rare Side Effects

  • Angioedema (swelling of face, lips, tongue)
  • Severe hypotension
  • Acute renal failure or worsening kidney function
  • Hepatic injury (elevated liver enzymes)
  • Neutropenia or agranulocytosis
  • Anaphylactic reactions

Precautions & Warnings

  • Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential complications.
  • Monitor renal function: assess serum creatinine and eGFR before and during treatment.
  • Check electrolytes: regularly measure serum potassium, especially in patients on potassium‑sparing agents.
  • Use caution in volume‑depleted or heart‑failure patients: risk of excessive blood‑pressure drop.
  • Avoid concurrent aliskiren in diabetic patients: increased risk of renal impairment.
  • Review NSAID use: may blunt antihypertensive effect and affect kidney function.
  • Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Irbesartan can interact with several medicines, requiring either avoidance or close monitoring.

Major Interactions (Avoid)

  • Aliskiren in patients with diabetes: heightened risk of renal dysfunction.
  • Potassium‑sparing diuretics or supplements: may cause dangerous hyperkalaemia.
  • Strong CYP3A4 inhibitors (e.g., itraconazole, ketoconazole): increase irbesartan plasma concentrations.
  • Combined ARB/ACE‑inhibitor therapy: risk of severe hypotension and renal injury.

Moderate Interactions (Monitor Closely)

  • NSAIDs: can reduce antihypertensive efficacy and impair renal function.
  • Lithium: may raise lithium levels, necessitating serum monitoring.
  • Loop or thiazide diuretics: may enhance hypotensive effect, dose adjustment may be needed.
  • Rifampin or other CYP3A4 inducers: may lower irbesartan levels, monitor blood pressure.

Frequently Asked Questions

Ifirmasta contains irbesartan and is prescribed to lower high blood pressure and to protect kidney function in adults with hypertension or type 2 diabetes‑related renal impairment. It helps reduce the risk of cardiovascular events and slows the progression of diabetic nephropathy.

Irbesartan blocks angiotensin II type 1 (AT1) receptors, preventing the hormone from causing vasoconstriction, aldosterone release, and sodium‑water retention. This leads to relaxed blood vessels, lower peripheral resistance, reduced blood pressure, and decreased pressure within the kidney’s filtering units.

The appropriate dose of Ifirmasta is determined by the prescribing healthcare professional based on the individual’s blood‑pressure goals, kidney function, and overall health status. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of irbesartan in pregnancy has not been established, and the drug is generally avoided because of potential fetal toxicity. Limited data are available for breastfeeding; therefore, a healthcare provider should evaluate the risk‑benefit ratio before use in nursing mothers.

To request Ifirmasta, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ifirmasta (an ARB) offers blood‑pressure control similar to ACE inhibitors but without the characteristic cough associated with ACE inhibition. It is often chosen for patients who cannot tolerate ACE inhibitors or who need additional renal protection in diabetic kidney disease.

Ifirmasta tablets should be stored at ambient temperature below 25 °C, in the original packaging, and protected from moisture and direct sunlight. Keep the product out of reach of children and do not use after the expiry date.

Ifirmasta is taken orally as a whole tablet with a glass of water. It may be taken with or without food, and the dose is usually taken once daily, unless the prescriber advises otherwise.

Patients should be alert for signs of angioedema (swelling of the face, lips, tongue), severe dizziness or fainting indicating hypotension, sudden worsening of kidney function, and markedly elevated potassium levels, which can cause cardiac rhythm disturbances.

Ifirmasta should not be used by individuals with known hypersensitivity to irbesartan or any ARB, those with severe hepatic impairment, or patients taking aliskiren concurrently if they have diabetes. Caution is also advised for patients with existing hyperkalaemia or severe renal insufficiency.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Irbesartan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT